PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Symptom | C0018801|heart failure |
| Sentences | 128 |
| PubMedID- 26005421 | The purpose of the allstar study (allogeneic heart stem cells to achieve myocardial regeneration) is to investigate the safety and efficacy of the treatment in decreasing infarct size, with the primary efficacy endpoint being the relative percentage improvement in infarct size as assessed using magnetic resonance imaging at 6 and 12 months post-infusion (allogeneic heart stem cells to achieve myocardial regeneration (allstar) (nct01458405)2. more recently, a phase i/ii randomized, double-blind, placebo controlled clinical trial was proposed by a european study group initiative (care-mi) to investigate the therapeutic role of allogeneic cscs in patients with congestive heart failure due to myocardial infarction (crisostomo et al., 2015). |
| PubMedID- 24753702 | Trends in hospitalized acute myocardial infarction patients with heart failure in korea at 1998 and 2008. |
| PubMedID- 25128086 | Adverse remodeling following myocardial infarction (mi) leading to heart failure is driven by an imbalanced resolution of inflammation. |
| PubMedID- 24826250 | Here we report a surgical treatment experience in an 81-year-old patient who suffered from heart failure due to acute myocardial infarction and went on to be diagnosed with valvular disease and vsd. |
| PubMedID- 22947202 | Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction. |
| PubMedID- 22285448 | Severity of the cardiac impairment determines whether digitalis prolongs or reduces survival of rats with heart failure due to myocardial infarction. |
| PubMedID- 23634302 | One of the events was a myocardial infarction with subsequent clinical heart failure (this occurred in arm b). |
| PubMedID- 20354030 | Aims: to determine the association between obesity and outcomes in post-acute myocardial infarction (ami) patients with systolic heart failure (hf). |
| PubMedID- 21822708 | We evaluated the incidence of major adverse cardiac events (mace) that included all-cause death, nonfatal myocardial infarction, and rehospitalization with heart failure or angina pectoris. |
| PubMedID- 22019275 | The number of leads with fragmented qrs is independently associated with cardiac death or hospitalization for heart failure in patients with prior myocardial infarction. |
| PubMedID- 23960370 | However, the causes of death from ad have been determined to be heart failure due to myocardial infarction, aortic regurgitation or cardiac tamponade, cerebral infarction, multiple organ failure due to ischemia or circulatory insufficiency, or bleeding due to rupture of the aorta. |
| PubMedID- 23735368 | An 81-year-old female was referred for myocardial infarction with heart failure. |
| PubMedID- 25559869 | heart failure due to myocardial infarction (mi) remains the leading cause of death worldwide due to the inability of myocardial tissue to regenerate following infarction. |
| PubMedID- 20671241 | Rationale: myocardial infarction (mi) leads to heart failure (hf) and premature death. |
| PubMedID- 22006050 | Patients were excluded if they had uncontrolled hypertension (> 140/90 mmhg), nyha class iii or iv heart failure, a history of cerebrovascular accident, myocardial infarction, unstable angina, or coronary artery stenting within 6 months of enrollment, or a history of venous thrombosis within 12 weeks of enrollment. |
| PubMedID- 25974948 | Inadequate replacement of lost ventricular myocardium from myocardial infarction leads to heart failure. |
| PubMedID- 23537961 | Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review. |
| PubMedID- 22004043 | myocardial infarction (mi) with resultant congestive heart failure (chf) is a leading cause of mortality and morbidity in developed countries. |
| PubMedID- 21850540 | Despite some differences in the pattern of heart failure due to myocardial infarction and aging with respect to their etiology and sequence of events, evidence has been presented to show that subcellular remodeling plays a critical role in the occurrence of intracellular ca(2+)-overload and development of cardiac dysfunction in both types of failing heart. |
| PubMedID- 21742099 | Growth differentiation factor 15 (gdf-15) has an established role as a marker for risk stratification and mortality both in patients after acute myocardial infarction and in patients with heart failure. |
| PubMedID- 23553674 | In order to examine the reversibility of heart failure due to myocardial infarction (mi) by beta-adrenoceptor blockade, 12 weeks infarcted rats were treated with or without metoprolol (50 mg/kg/day) for 8 weeks. |
| PubMedID- 20081109 | Glp-1 improves left ventricular ejection fraction (lvef) in dogs with heart failure (hf) and in patients with acute myocardial infarction. |
| PubMedID- 25797248 | New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor. |
| PubMedID- 21755036 | This concept is reinforced by the beneficial effects of carvedilol for the reduction in morbidity and mortality in patients after myocardial infarction and with systolic congestive heart failure . |
| PubMedID- 26225841 | Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction. |
| PubMedID- 25367056 | We report the case of a 4-year-old italian child submitted to heart transplant, at 18 months old, for end-stage heart failure due to extensive myocardial infarction of the left ventricle and diffuse coronary calcifications. |
| PubMedID- 25722046 | Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction. |
| PubMedID- 21122202 | The use of recombinant human b-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention. |
| PubMedID- 25142445 | He was diagnosed with heart failure due to an old myocardial infarction. |
| PubMedID- 22419888 | Exogenous hydrogen sulfide (h2s) leads to down-regulation of inflammatory responses and provides myocardial protection during acute ischemia/reperfusion injury; however its role during chronic heart failure (chf) due to myocardial infarction (mi) is yet to be unveiled. |
| PubMedID- 23741440 | heart failure (hf) due to myocardial infarction (mi) is one of the major health care issues in the world and leads to a high rate of hospitalization and mortality. |
| PubMedID- 26065643 | The benefits of aldosterone blockers (abs) in patients after myocardial infarction (mi) with heart failure have been well demonstrated.1 the eplerenone post-acute myocardial infarction heart failure efficacy and survival study1 reported that low doses of ab decreased the incidence of cardiovascular mortality among patients with moderate to severe heart failure after mi, with a 21% reduction rate of sudden death from cardiac causes. |
| PubMedID- 21756327 | myocardial infarction (mi) often leads to heart failure (hf), which makes mi a leading source of morbidity and hospitalizations 1. |
| PubMedID- 25178849 | We report a case of css masquerading as a non-st elevation myocardial infarction with heart failure. |
| PubMedID- 23827578 | myocardial infarction, a main cause of heart failure, leads to loss of cardiac tissue impairment of left ventricular function. |
| PubMedID- 26071031 | Acute myocardial infarction patients with heart failure or diabetes grouped by their eligibility for spironolactone in 2001, 2006, and 2011. ideal: patients with a left ventricular ejection fraction (lvef) ≤40% and without contraindications to spironolactone; contraindicated: patients with a contraindication (serum potassium >5 mmol/l, or serum creatinine >2.5 mg/dl men or >2.0 mg/dl women, or documented allergy to spironolactone); not indicated: patients with neither indication (ie, lvef >40%) nor contraindication to spironolactone; unknown indications: patients whose lvef was not measured during the hospitalization. |
| PubMedID- 25911595 | A 64-year-old female, who had undergone cabg previously, was admitted to our hospital because of non-st elevation myocardial infarction with acute heart failure. |
| PubMedID- 22929168 | Patients with severe carotid artery stenosis > 70% were compared to those without significant disease in table 4. congestive heart failure (chf), history of myocardial infarction, and recent or remote smoking history were also found to be significant variables. |
| PubMedID- 19949891 | This study investigated whether improvement in cardiac function and attenuation of cardiac remodeling by some beta-adrenoceptor (beta-ar) antagonists were associated with a depression in sympathetic activity in congestive heart failure (chf) due to myocardial infarction (mi). |
| PubMedID- 26070595 | The role of urine neutrophil gelatinase--associated lipocalin (ngal) in acute heart failure in patients with st--elevation myocardial infarction. |
| PubMedID- PMC3844577 | Surgical intervention on rca dissection was successful with uneventful f-up, patient with lm dissection underwent rescue surgery with double sv grafting, but died however at 4th postoperative day of intractable heart failure due to large myocardial infarction. |
| PubMedID- 21029374 | Validation of the cardiovascular regenerative potential of adult stem and progenitor cells is a prerequisite step towards advancing cell therapy to patients suffering from ischaemic heart failure associated with myocardial infarction or congenital heart diseases 1; although still in its infancy, this challenge holds great promise for the future. |
| PubMedID- 20438292 | Material and methods: in the prospective, placebo-controlled, randomized trial, 149 consecutive acute myocardial infarction (ami) patients with heart failure undergoing primary pci received recombinant human bnp (rhbnp) or placebo from the time of admission to 24 h after pci. |
| PubMedID- 24876877 | A new born infant whose mother ingested an herbal medication, blue cohosh, to promote uterine contractions presented with acute myocardial infarction associated with profound congestive heart failure and shock 7. |
| PubMedID- 24785883 | Objective: the predictors of in-hospital outcomes after primary percutaneous coronary intervention (pci) for acute myocardial infarction (ami) complicated with heart failure or cardiogenic shock at presentation remain unclear. |
| PubMedID- 23784267 | Uncontrolled hypertension specifically leads to increased fatal and non-fatal stroke and myocardial infarction (mi), along with heart failure and chronic kidney disease 3. |
| PubMedID- 21991485 | Hrv is a powerful predictor of cardiovascular mortality in healthy people, those who have had a myocardial infarction, and in patients with heart failure. |
| PubMedID- 21305486 | Conclusions: increased plasma homocysteine levels independently correlate with the severity of heart failure in patients with chronic myocardial infarction. |
| PubMedID- 22293888 | recently observed that ms predicted congestive heart failure independent of interim myocardial infarction in elderly finns . |
| PubMedID- 22549451 | Congestive heart failure due to myocardial infarction (mi) was induced by the coronary artery ligation in rats. |